European Urology Oncology

Slides:



Advertisements
Similar presentations
Volume 155, Issue 3, Pages (March 1996)
Advertisements

The PSA Era is not Over for Prostate Cancer
Volume 26, Issue 1, Pages (March 2017)
Prostate Cancer 2008: Challenges in Diagnosis and Management
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
European Urology Oncology
Volume 60, Issue 5, Pages (November 2011)
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic.
Volume 53, Issue 5, Pages (May 2008)
European Urology Oncology
Advances in the Treatment of Metastatic Prostate Cancer
Volume 71, Issue 5, Pages (May 2017)
Hormone Therapy for Prostate Cancer: Exploring Current Controversies
Volume 72, Issue 5, Pages (November 2017)
Volume 62, Issue 6, Pages (December 2012)
European Urology Oncology
Supplemental Figure 1: Kaplan-Meier Curves of overall survival based on clinical stage at presentation and treatment modality Kaplan-Meier analyses depicting.
Volume 71, Issue 1, Pages 1-3 (January 2017)
What is New in Hormone Therapy for Prostate Cancer in 2007?
Volume 68, Issue 3, Pages (September 2015)
Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals Liver Cancer - DOI: / Fig. 1. Flowchart of included.
Volume 184, Issue 4, Pages (October 2010)
Volume 67, Issue 3, Pages (March 2015)
Volume 70, Issue 5, Pages (November 2016)
European Urology Oncology
Volume 73, Issue 4, Pages (April 2018)
Volume 73, Issue 2, Pages (February 2018)
Thromboembolic Events Following Surgery for Prostate Cancer
The PSA Era is not Over for Prostate Cancer
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery
Volume 71, Issue 1, Pages (January 2017)
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care  Fred Saad, Carl Olsson, Claude C. Schulman 
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial  Eva Johansson,
Risk Factors for the Development of Bone Metastases in Prostate Cancer
Volume 72, Issue 4, Pages (October 2017)
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study  Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,
European Urology Oncology
What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006  Michel Soulié, Nicolas Mottet, Laurent Salomon, Jacques Irani,
Bone Health in Patients With Prostate Cancer: Monitoring and Diagnosis
European Urology Oncology
Volume 68, Issue 1, Pages (July 2015)
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Long-Term Hormonal Therapy: Who Would Benefit?
European Urology Oncology
European Urology Oncology
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer  Felix Preisser, Michele Marchioni, Sebastiano.
European Urology Oncology
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis  Joseph Sargon Joseph, Vincent.
European Urology Oncology
Prostate Cancer 2008: Challenges in Diagnosis and Management
Axel Heidenreich  European Urology Supplements 
Improving Flexibility and Quality of Life for Your Patients: A Must?
Highlighting Unmet Needs: Real Patients, Difficult Choices
European Urology Oncology
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Axel Heidenreich  European Urology Supplements 
European Urology Oncology
Volume 51, Issue 5, Pages (May 2007)
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
European Urology Oncology
Presentation transcript:

European Urology Oncology Risk of Depression After Radical Prostatectomy—A Nationwide Registry-based Study  Anne Sofie Friberg, Susanne Oksbjerg Dalton, Signe Benzon Larsen, Elisabeth W. Andersen, Anja Krøyer, John Thomas Helgstrand, Martin Andreas Røder, Christoffer Johansen, Klaus Brasso  European Urology Oncology  DOI: 10.1016/j.euo.2019.06.020 Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 1 Flowchart illustrating the formation of the analysed cohort of 5570 men treated with radical prostatectomy in Denmark from 1998 to 2011. European Urology Oncology DOI: (10.1016/j.euo.2019.06.020) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 2 Cumulative incidence of depression with years since surgery/index date in the 5570 prostate cancer patients treated with radical prostatectomy in Denmark from 1998 to 2011 compared with 54276 cancer-free men, age matched to prostate cancer patients at the time of diagnosis and followed up since the time of surgery. European Urology Oncology DOI: (10.1016/j.euo.2019.06.020) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 3 Cumulative incidence of depression with years since surgery/index date in the background population of 54276 cancer-free age-matched men compared with 5570 men treated with radical prostatectomy (RP) in Denmark from 1998 to 2011 according to subsequent treatment with androgen deprivation therapy (ADT) and salvage radiation (SR). European Urology Oncology DOI: (10.1016/j.euo.2019.06.020) Copyright © 2019 European Association of Urology Terms and Conditions